Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Looking for participantsNCT07333183
What this trial is testing

Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease (ILD)Lung Diseases+3 more
Pulmovant, Inc. 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05649722
What this trial is testing

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease
Insmed Incorporated 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT07285655
What this trial is testing

Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Who this might be right for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc. 344
Testing effectiveness (Phase 2)Active Not RecruitingNCT06635850
What this trial is testing

Mosliciguat in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseLung Diseases+3 more
Pulmovant, Inc. 135
Early research (Phase 1)Study completedNCT02267655
What this trial is testing

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis
Bellerophon 8
Large-scale testing (Phase 3)Ended earlyNCT00879229
What this trial is testing

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Gilead Sciences 40
Testing effectiveness (Phase 2)WithdrawnNCT00323024
What this trial is testing

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
NITROX, LLC 72
Not applicableLooking for participantsNCT06388421
What this trial is testing

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases and HypoxiaPulmonary HypertensionInterstitial Lung Disease
United Therapeutics 900
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07441278
What this trial is testing

A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NS Pharma, Inc. 177
Not applicableAvailableNCT05572996
What this trial is testing

Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseCombined Pulmonary Fibrosis and Emphysema
Ferrer Internacional S.A.
Large-scale testing (Phase 3)Temporarily pausedNCT07181382
What this trial is testing

Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Associated With Interstitial Lung Disease
GB002, Inc. 480
Testing effectiveness (Phase 2)Looking for participantsNCT07175038
What this trial is testing

ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease
AllRock Bio, Inc. 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07234032
What this trial is testing

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease
Insmed Incorporated 344
Testing effectiveness (Phase 2)Ended earlyNCT02138825
What this trial is testing

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Who this might be right for
Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Bayer 147
Large-scale testing (Phase 3)Looking for participantsNCT07179380
What this trial is testing

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease
Insmed Incorporated 344
Large-scale testing (Phase 3)WithdrawnNCT03726398
What this trial is testing

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH

Who this might be right for
Interstitial Lung DiseaseSclerodermaPulmonary Hypertension
Franz Rischard, DO
Large-scale testing (Phase 3)Active Not RecruitingNCT04691154
What this trial is testing

Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases
Liquidia Technologies, Inc. 28
Not applicableAvailableNCT06939647
What this trial is testing

An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension, Interstitial Lung Disease
Insmed Incorporated
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Load More Results